Histone Deacetylase (HDAC) Inhibition as a Novel Treatment for Diabetes Mellitus

Both common forms of diabetes have an inflammatory pathogenesis in which immune and metabolic factors converge on interleukin-1β as a key mediator of insulin resistance and β-cell failure. In addition to improving insulin resistance and preventing β-cell inflammatory damage, there is evidence of genetic association between diabetes and histone deacetylases (HDACs); and HDAC inhibitors (HDACi) promote β-cell development, proliferation, differentiation and function and positively affect late diabetic microvascular complications. Here we review this evidence and propose that there is a strong rationale for preclinical studies and clinical trials with the aim of testing the utility of HDACi as a novel therapy for diabetes.

[1]  F. Chiarelli,et al.  Weight gain following treatment with valproic acid: pathogenetic mechanisms and clinical implications , 2011, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[2]  D. Eizirik,et al.  Mcl-1 downregulation by pro-inflammatory cytokines and palmitate is an early event contributing to β-cell apoptosis , 2011, Cell Death and Differentiation.

[3]  L. Joosten,et al.  The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity. , 2010, Cell metabolism.

[4]  T. Mandrup-Poulsen.  IAPP boosts islet macrophage IL-1 in type 2 diabetes , 2010, Nature Immunology.

[5]  Christine E. Becker,et al.  Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes , 2010, Nature Immunology.

[6]  C. Dinarello,et al.  Lysine deacetylases are produced in pancreatic beta cells and are differentially regulated by proinflammatory cytokines , 2010, Diabetologia.

[7]  P. Froguel,et al.  The emerging genetics of type 2 diabetes. , 2010, Trends in molecular medicine.

[8]  Shahid Husain,et al.  Inhibition of histone deacetylase protects the retina from ischemic injury. , 2010, Investigative ophthalmology & visual science.

[9]  John A. Todd,et al.  Genetics of Type 1 Diabetes: What's Next? , 2010, Diabetes.

[10]  R. Natarajan,et al.  The role of epigenetics in the pathology of diabetic complications. , 2010, American journal of physiology. Renal physiology.

[11]  T. Golub,et al.  Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease , 2010, Proceedings of the National Academy of Sciences.

[12]  C. Dinarello,et al.  The unique hypusine modification of eIF5A promotes islet beta cell inflammation and dysfunction in mice. , 2010, The Journal of clinical investigation.

[13]  K. Schroder,et al.  Differential effects of selective HDAC inhibitors on macrophage inflammatory responses to the Toll‐like receptor 4 agonist LPS , 2010, Journal of leukocyte biology.

[14]  Young-Bum Kim,et al.  Molecular Mechanism of Insulin Resistance in Obesity and Type 2 Diabetes , 2010, The Korean journal of internal medicine.

[15]  B. Palmer,et al.  The Histone Deacetylase Inhibitor ITF2357 Decreases Surface CXCR4 and CCR5 Expression on CD4+ T-Cells and Monocytes and is Superior to Valproic Acid for Latent HIV-1 Expression in Vitro , 2010, Journal of acquired immune deficiency syndromes.

[16]  P. Marchetti,et al.  p53 Up-regulated Modulator of Apoptosis (PUMA) Activation Contributes to Pancreatic β-Cell Apoptosis Induced by Proinflammatory Cytokines and Endoplasmic Reticulum Stress* , 2010, The Journal of Biological Chemistry.

[17]  Rebecca A. Simmons,et al.  Epigenetic mechanisms in the development of type 2 diabetes , 2010, Trends in Endocrinology & Metabolism.

[18]  M. Hargreaves,et al.  Histone modifications and skeletal muscle metabolic gene expression , 2010, Clinical and experimental pharmacology & physiology.

[19]  D. Eizirik,et al.  ER Stress in Pancreatic β Cells: The Thin Red Line Between Adaptation and Failure , 2010, Science Signaling.

[20]  Sunhee C. Lee,et al.  Histone Deacetylase Inhibitors Suppress the Expression of Inflammatory and Innate Immune Response Genes in Human Microglia and Astrocytes , 2010, Journal of Neuroimmune Pharmacology.

[21]  Torben F. Ørntoft,et al.  Cytokines Interleukin-1β and Tumor Necrosis Factor-α Regulate Different Transcriptional and Alternative Splicing Networks in Primary β-Cells , 2009, Diabetes.

[22]  S. Grant,et al.  Bim Upregulation by Histone Deacetylase Inhibitors Mediates Interactions with the Bcl-2 Antagonist ABT-737: Evidence for Distinct Roles for Bcl-2, Bcl-xL, and Mcl-1 , 2009, Molecular and Cellular Biology.

[23]  H. Ellingsgaard,et al.  Pancreatic islet inflammation in type 2 diabetes: From α and β cell compensation to dysfunction , 2009, Archives of physiology and biochemistry.

[24]  Xuan Wang,et al.  Increased Hsp70 expression attenuates cytokine-induced cell death in islets of Langerhans from Shb knockout mice. , 2009, Biochemical and biophysical research communications.

[25]  J. Nerup,et al.  Ultrastructural studies of time-course and cellular specificity of interleukin-1 mediated islet cytotoxicity. , 2009, Acta pathologica, microbiologica, et immunologica Scandinavica. Section C, Immunology.

[26]  M. Mann,et al.  Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions , 2009, Science.

[27]  M. Atkinson,et al.  The pancreas in human type 1 diabetes: providing new answers to age-old questions , 2009, Current opinion in endocrinology, diabetes, and obesity.

[28]  P. Woster,et al.  A novel histone deacetylase inhibitor prevents IL‐1β induced metabolic dysfunction in pancreatic β‐cells , 2009, Journal of cellular and molecular medicine.

[29]  D. Eizirik,et al.  Signaling by IL-1β+IFN-γ and ER stress converge on DP5/Hrk activation: a novel mechanism for pancreatic β-cell apoptosis , 2009, Cell Death and Differentiation.

[30]  A. Vaag,et al.  Sustained Effects of Interleukin-1 Receptor Antagonist Treatment in Type 2 Diabetes , 2009, Diabetes Care.

[31]  S. Paraskevas,et al.  Proinflammatory Cytokines Activate the Intrinsic Apoptotic Pathway in β-Cells , 2009, Diabetes.

[32]  J. Todd,et al.  No association of multiple type 2 diabetes loci with type 1 diabetes , 2009, Diabetologia.

[33]  Helen Schuilenburg,et al.  Genome-wide association study and meta-analysis finds over 40 loci affect risk of type 1 diabetes , 2009, Nature Genetics.

[34]  C. Mcintosh,et al.  Glucose-dependent Insulinotropic Polypeptide and Glucagon-like Peptide-1 Modulate β-Cell Chromatin Structure* , 2009, Journal of Biological Chemistry.

[35]  A. Bonen.  PGC-1alpha-induced improvements in skeletal muscle metabolism and insulin sensitivity. , 2009, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.

[36]  M. Weiss.  Proinsulin and the Genetics of Diabetes Mellitus* , 2009, The Journal of Biological Chemistry.

[37]  R. McManus,et al.  NF-κB regulation: the nuclear response , 2009, Journal of cellular and molecular medicine.

[38]  S. Richardson,et al.  Analysis of islet inflammation in human type 1 diabetes , 2009, Clinical and experimental immunology.

[39]  M. Sweet,et al.  Histone deacetylase inhibitors in inflammatory disease. , 2009, Current topics in medicinal chemistry.

[40]  Nathan L. Vanderford,et al.  The Stability and Transactivation Potential of the Mammalian MafA Transcription Factor Are Regulated by Serine 65 Phosphorylation* , 2009, Journal of Biological Chemistry.

[41]  Li Li,et al.  Combination of GLP-1 and sodium butyrate promote differentiation of pancreatic progenitor cells into insulin-producing cells. , 2008, Tissue & cell.

[42]  Mark I McCarthy,et al.  Type 2 diabetes: new genes, new understanding. , 2008, Trends in genetics : TIG.

[43]  D. R. Laybutt,et al.  Cytokine-Induced β-Cell Death Is Independent of Endoplasmic Reticulum Stress Signaling , 2008, Diabetes.

[44]  D. Stemple,et al.  Organ-specific requirements for Hdac1 in liver and pancreas formation , 2008, Developmental biology.

[45]  R. Scharfmann,et al.  Histone Deacetylase Inhibitors Modify Pancreatic Cell Fate Determination and Amplify Endocrine Progenitors , 2008, Molecular and Cellular Biology.

[46]  E. Olson,et al.  HDAC4 inhibits cell‐cycle progression and protects neurons from cell death , 2008, Developmental neurobiology.

[47]  D. Stoffers,et al.  Development of type 2 diabetes following intrauterine growth retardation in rats is associated with progressive epigenetic silencing of Pdx1. , 2008, The Journal of clinical investigation.

[48]  S. Devaskar,et al.  Histone Code Modifications Repress Glucose Transporter 4 Expression in the Intrauterine Growth-restricted Offspring* , 2008, Journal of Biological Chemistry.

[49]  Z. Gong,et al.  Histone deacetylase 3 (hdac3) is specifically required for liver development in zebrafish. , 2008, Developmental biology.

[50]  L. Castellani,et al.  The antiinflammatory cytokine interleukin-1 receptor antagonist protects from high-fat diet-induced hyperglycemia. , 2008, Endocrinology.

[51]  A. Strasser,et al.  Proapoptotic BH3-Only Protein Bid Is Essential For Death Receptor–Induced Apoptosis of Pancreatic β-Cells , 2008, Diabetes.

[52]  D. Cortez,et al.  Deletion of histone deacetylase 3 reveals critical roles in S phase progression and DNA damage control. , 2008, Molecular cell.

[53]  B. Kemp,et al.  AMP-Activated Protein Kinase Regulates GLUT4 Transcription by Phosphorylating Histone Deacetylase 5 , 2008, Diabetes.

[54]  A. Olson,et al.  GLUT4 Enhancer Factor (GEF) Interacts with MEF2A and HDAC5 to Regulate the GLUT4 Promoter in Adipocytes* , 2008, Journal of Biological Chemistry.

[55]  D. Eizirik,et al.  The role for endoplasmic reticulum stress in diabetes mellitus. , 2008, Endocrine reviews.

[56]  M. Donath,et al.  Cytokines and β-Cell Biology: from Concept to Clinical Translation , 2008 .

[57]  M. Link,et al.  Parasympathetic response in chick myocytes and mouse heart is controlled by SREBP. , 2008, The Journal of clinical investigation.

[58]  Afshin Samali,et al.  Cytokine-induced β-cell apoptosis is NO-dependent, mitochondria-mediated and inhibited by BCL-XL , 2007, Journal of cellular and molecular medicine.

[59]  M. Kitagawa,et al.  Critical and Functional Regulation of CHOP (C/EBP Homologous Protein) through the N-terminal Portion* , 2007, Journal of Biological Chemistry.

[60]  M. V. Suresh,et al.  Regulatory roles for histone deacetylation in IL-1β-induced nitric oxide release in pancreatic β-cells , 2007, Journal of cellular and molecular medicine.

[61]  A. Eychène,et al.  GSK-3-mediated phosphorylation enhances Maf-transforming activity. , 2007, Molecular cell.

[62]  Yuanyuan Shi,et al.  Induction of GRP78 by valproic acid is dependent upon histone deacetylase inhibition. , 2007, Bioorganic & medicinal chemistry letters.

[63]  K. Yasuda,et al.  MafA Stability in Pancreatic β Cells Is Regulated by Glucose and Is Dependent on Its Constitutive Phosphorylation at Multiple Sites by Glycogen Synthase Kinase 3 , 2007, Molecular and Cellular Biology.

[64]  R. Rizza,et al.  High Expression Rates of Human Islet Amyloid Polypeptide Induce Endoplasmic Reticulum Stress–Mediated β-Cell Apoptosis, a Characteristic of Humans With Type 2 but Not Type 1 Diabetes , 2007, Diabetes.

[65]  H. Ha,et al.  Histone deacetylase inhibitors: a novel class of therapeutic agents in diabetic nephropathy. , 2007, Kidney international. Supplement.

[66]  G. Korbutt,et al.  Generation of Insulin‐Producing Islet‐Like Clusters from Human Embryonic Stem Cells , 2007, Stem cells.

[67]  Tatsuhiko Kodama,et al.  SOX6 Suppresses Cyclin D1 Promoter Activity by Interacting with β-Catenin and Histone Deacetylase 1, and Its Down-regulation Induces Pancreatic β-Cell Proliferation* , 2007, Journal of Biological Chemistry.

[68]  E. Oetjen,et al.  Inhibition of MafA transcriptional activity and human insulin gene transcription by interleukin-1β and mitogen-activated protein kinase kinase kinase in pancreatic islet beta cells , 2007, Diabetologia.

[69]  C. Mantzoros,et al.  Peroxisome Proliferator Activator Receptor γ Coactivator-1 Expression Is Reduced in Obesity , 2007, Journal of Biological Chemistry.

[70]  T. Wilkin.  Changing perspectives in diabetes: their impact on its classification , 2007, Diabetologia.

[71]  Allan Vaag,et al.  Interleukin-1-receptor antagonist in type 2 diabetes mellitus. , 2007, The New England journal of medicine.

[72]  R. Baron,et al.  Anti‐rheumatic activities of histone deacetylase (HDAC) inhibitors in vivo in collagen‐induced arthritis in rodents , 2007, British journal of pharmacology.

[73]  R. Mirmira,et al.  Glucose Regulation of Insulin Gene Transcription and Pre-mRNA Processing in Human Islets , 2007, Diabetes.

[74]  J. Kench,et al.  Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes , 2007, Diabetologia.

[75]  S. G. Rønn,et al.  Inhibition of histone deacetylases prevents cytokine-induced toxicity in beta cells , 2007, Diabetologia.

[76]  E. Montanya,et al.  Adenoviral overproduction of interleukin-1 receptor antagonist increases beta cell replication and mass in syngeneically transplanted islets, and improves metabolic outcome , 2007, Diabetologia.

[77]  M. Rohde,et al.  Chromatin‐Remodeling Factors Allow Differentiation of Bone Marrow Cells into Insulin‐Producing Cells , 2006, Stem cells.

[78]  C. Ricordi,et al.  Sodium butyrate activates genes of early pancreatic development in embryonic stem cells. , 2006, Cloning and stem cells.

[79]  M. Knip,et al.  Characterization of Insulin Secretion in Valproate‐treated Patients with Epilepsy , 2006, Epilepsia.

[80]  P. Serup,et al.  Specifying pancreatic endocrine cell fates , 2006, Mechanisms of Development.

[81]  André Scheen.  Diabetes mellitus in the elderly: insulin resistance and/or impaired insulin secretion? , 2005, Diabetes & metabolism.

[82]  H. Ishii,et al.  Histone Deacetylase Inhibitor Depsipeptide (FK228) Induces Apoptosis in Leukemic Cells by Facilitating Mitochondrial Translocation of Bax, Which Is Enhanced by the Proteasome Inhibitor Bortezomib , 2005, Acta Haematologica.

[83]  P. De Meyts,et al.  Role of histone and transcription factor acetylation in diabetes pathogenesis , 2005, Diabetes/metabolism research and reviews.

[84]  D. Levy,et al.  Disruption of the gamma-interferon signaling pathway at the level of signal transducer and activator of transcription-1 prevents immune destruction of beta-cells. , 2005, Diabetes.

[85]  K. Yasuda,et al.  Synergistic activation of the insulin gene promoter by the beta-cell enriched transcription factors MafA, Beta2, and Pdx1. , 2005, Biochimica et biophysica acta.

[86]  G. Stephanopoulos,et al.  Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis , 2005, Journal of Neuroimmunology.

[87]  F. Ortis,et al.  Cytokines downregulate the sarcoendoplasmic reticulum pump Ca2+ ATPase 2b and deplete endoplasmic reticulum Ca2+, leading to induction of endoplasmic reticulum stress in pancreatic beta-cells. , 2005, Diabetes.

[88]  A. Mosley,et al.  The Pancreatic Duodenal Homeobox-1 Protein (Pdx-1) Interacts with Histone Deacetylases Hdac-1 and Hdac-2 on Low Levels of Glucose* , 2004, Journal of Biological Chemistry.

[89]  J. Corbett,et al.  PPARγ ligands induce ER stress in pancreatic β-cells: ER stress activation results in attenuation of cytokine signaling , 2004 .

[90]  C. Kaiser,et al.  Acetylation of insulin receptor substrate-1 is permissive for tyrosine phosphorylation , 2004, BMC Biology.

[91]  A. K. Cardozo,et al.  The Cytokine Interleukin-1β Reduces the Docking and Fusion of Insulin Granules in Pancreatic β-Cells, Preferentially Decreasing the First Phase of Exocytosis* , 2004, Journal of Biological Chemistry.

[92]  A. Mosley,et al.  Glucose regulation of insulin gene expression requires the recruitment of p300 by the beta-cell-specific transcription factor Pdx-1. , 2004, Molecular endocrinology.

[93]  L. Augenlicht,et al.  Requirement of Histone Deacetylase Activity for Signaling by STAT1* , 2004, Journal of Biological Chemistry.

[94]  I. Chang,et al.  Role of Calcium in Pancreatic Islet Cell Death by IFN-γ/TNF-α1 , 2004, The Journal of Immunology.

[95]  P. Halban,et al.  Leptin modulates beta cell expression of IL-1 receptor antagonist and release of IL-1beta in human islets. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[96]  S. McGee,et al.  Exercise and myocyte enhancer factor 2 regulation in human skeletal muscle. , 2004, Diabetes.

[97]  Rama Natarajan,et al.  In Vivo Chromatin Remodeling Events Leading to Inflammatory Gene Transcription under Diabetic Conditions* , 2004, Journal of Biological Chemistry.

[98]  Ivan V. Gregoretti,et al.  Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis. , 2004, Journal of molecular biology.

[99]  R. Stein,et al.  Acetylation of the BETA2 Transcription Factor by p300-associated Factor Is Important in Insulin Gene Expression* , 2004, Journal of Biological Chemistry.

[100]  D. Skalnik,et al.  Histone deacetylase activity is required for embryonic stem cell differentiation , 2004, Genesis.

[101]  S. Kyrylenko,et al.  Regulation of microglial inflammatory response by histone deacetylase inhibitors , 2003, Journal of neurochemistry.

[102]  C. Mathieu,et al.  Prevention of primary non-function of islet xenografts in autoimmune diabetic NOD mice by anti-inflammatory agents , 2003, Diabetologia.

[103]  E. Trinka,et al.  Valproic acid modulates islet cell insulin secretion: a possible mechanism of weight gain in epilepsy patients , 2003, Epilepsy Research.

[104]  A. Mosley,et al.  Glucose Regulates Insulin Gene Transcription by Hyperacetylation of Histone H4* , 2003, Journal of Biological Chemistry.

[105]  M. A. Reddy,et al.  High glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cells. , 2003, Diabetes.

[106]  Jae-Hyoung Cho,et al.  Selective β-Cell Loss and α-Cell Expansion in Patients with Type 2 Diabetes Mellitus in Korea , 2003 .

[107]  Joachim Spranger,et al.  Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. , 2003, Diabetes.

[108]  R. Mirmira,et al.  Transcription factors direct the development and function of pancreatic β cells , 2003, Trends in Endocrinology & Metabolism.

[109]  C. Sardet,et al.  Post-activation Turn-off of NF-κB-dependent Transcription Is Regulated by Acetylation of p65* , 2003, The Journal of Biological Chemistry.

[110]  H. Takigawa-Imamura,et al.  Stimulation of Glucose Uptake in Muscle Cells by Prolonged Treatment with Scriptide, a Histone Deacetylase Inhibitor , 2003, Bioscience, biotechnology, and biochemistry.

[111]  Robert A. Rizza,et al.  β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes , 2003, Diabetes.

[112]  A. Cooke,et al.  Nondepleting anti-CD4 and soluble interleukin-1 receptor prevent autoimmune destruction of syngeneic islet grafts in diabetic NOD mice1 , 2002, Transplantation.

[113]  D. O’Carroll,et al.  Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression , 2002, The EMBO journal.

[114]  D. Melton,et al.  Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors. , 2002, Development.

[115]  M. Knip,et al.  Serum Insulin and Leptin Levels in Valproate‐associated Obesity , 2002, Epilepsia.

[116]  Carla J Greenbaum,et al.  Insulin resistance in type 1 diabetes , 2002, Diabetes/metabolism research and reviews.

[117]  F. Chiarelli,et al.  Insulin Resistance in Epileptic Girls Who Gain Weight After Therapy With Valproic Acid , 2002, Journal of child neurology.

[118]  Colin A. Johnson,et al.  Human Class I Histone Deacetylase Complexes Show Enhanced Catalytic Activity in the Presence of ATP and Co-immunoprecipitate with the ATP-dependent Chaperone Protein Hsp70* , 2002, The Journal of Biological Chemistry.

[119]  K. Silver,et al.  Genetics of insulin resistance , 2002, Current diabetes reports.

[120]  R. Stein,et al.  Insulin Gene Transcription Is Mediated by Interactions between the p300 Coactivator and PDX-1, BETA2, and E47 , 2002, Molecular and Cellular Biology.

[121]  T. Mandrup-Poulsen,et al.  A choice of death – the signal-transduction of immune-mediated beta-cell apoptosis , 2001, Diabetologia.

[122]  F. Pociot,et al.  A genomewide scan for type 1-diabetes susceptibility in Scandinavian families: identification of new loci with evidence of interactions. , 2001, American journal of human genetics.

[123]  Sandy D. Westerheide,et al.  The p65 (RelA) Subunit of NF-κB Interacts with the Histone Deacetylase (HDAC) Corepressors HDAC1 and HDAC2 To Negatively Regulate Gene Expression , 2001, Molecular and Cellular Biology.

[124]  D. Eizirik,et al.  Inhibition of cytokine-induced NF-kappaB activation by adenovirus-mediated expression of a NF-kappaB super-repressor prevents beta-cell apoptosis. , 2001, Diabetes.

[125]  E. Olson,et al.  Control of muscle development by dueling HATs and HDACs. , 2001, Current opinion in genetics & development.

[126]  D. Bernhard,et al.  The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[127]  Masataka Mori,et al.  Nitric oxide-induced apoptosis in pancreatic β cells is mediated by the endoplasmic reticulum stress pathway , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[128]  P. Puigserver,et al.  Restoration of insulin-sensitive glucose transporter (GLUT4) gene expression in muscle cells by the transcriptional coactivator PGC-1 , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[129]  E. Olson,et al.  Activation of the myocyte enhancer factor-2 transcription factor by calcium/calmodulin-dependent protein kinase-stimulated binding of 14-3-3 to histone deacetylase 5. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[130]  M. Trucco,et al.  Protection of Human Islets from the Effects of Interleukin-1β by Adenoviral Gene Transfer of an IκB Repressor* , 2000, The Journal of Biological Chemistry.

[131]  R. Stein,et al.  The RIPE3b1 Activator of the Insulin Gene Is Composed of a Protein(s) of Approximately 43 kDa, Whose DNA Binding Activity Is Inhibited by Protein Phosphatase Treatment* , 2000, The Journal of Biological Chemistry.

[132]  F. Guillemot,et al.  neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[133]  O. Madsen,et al.  Beta-cell maturation leads to in vitro sensitivity to cytotoxins. , 1999, Diabetes.

[134]  G. Korbutt,et al.  Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects beta-cells from cytokine-induced destruction. , 1999, Diabetes.

[135]  S. Guruswamy,et al.  Myocyte enhancer factor 2 (MEF2)-binding site is required for GLUT4 gene expression in transgenic mice. Regulation of MEF2 DNA binding activity in insulin-deficient diabetes. , 1998, The Journal of biological chemistry.

[136]  Arun J Sharma,et al.  p300 Mediates Transcriptional Stimulation by the Basic Helix-Loop-Helix Activators of the Insulin Gene , 1998, Molecular and Cellular Biology.

[137]  D. Eizirik,et al.  IL‐1 receptor antagonist inhibits recurrence of disease after syngeneic pancreatic islet transplantation to spontaneously diabetic non‐obese diabetic (NOD) mice , 1997, Clinical and experimental immunology.

[138]  P. Gruss,et al.  The Pax4 gene is essential for differentiation of insulin-producing β cells in the mammalian pancreas , 1997, Nature.

[139]  T. Mandrup-Poulsen,et al.  The role of interleukin-1 in the pathogenesis of IDDM , 1996, Diabetologia.

[140]  B. Hogan,et al.  PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. , 1996, Development.

[141]  M. Salminen,et al.  Improvement of Insulin Action in Diabetic Transgenic Mice Selectively Overexpressing GLUT4 in Skeletal Muscle , 1996, Diabetes.

[142]  H. Edlund,et al.  Insulin-promoter-factor 1 is required for pancreas development in mice , 1994, Nature.

[143]  J. Lakey,et al.  Human pancreatic islet beta-cell destruction by cytokines is independent of nitric oxide production. , 1994, The Journal of clinical endocrinology and metabolism.

[144]  D. Eizirik,et al.  TNF-α and IFN-γ potentiate the deleterious effects of IL-1β on mouse pancreatic islets mainly via generation of nitric oxide , 1994 .

[145]  D. Eizirik,et al.  Treatment With an Interleukin-1 Receptor Antagonist Protein Prolongs Mouse Islet Allograft Survival , 1993, Diabetes.

[146]  H. Ohlsson,et al.  IPF1, a homeodomain‐containing transactivator of the insulin gene. , 1993, The EMBO journal.

[147]  A. Rabinovitch,et al.  Destruction of Rat Islet Cell Monolayers by Cytokines: Synergistic Interactions of Interferon-γ, Tumor Necrosis Factor, Lymphotoxin, and Interleukin 1 , 1988, Diabetes.

[148]  J. Nerup,et al.  Human tumor necrosis factor potentiates human interleukin 1-mediated rat pancreatic beta-cell cytotoxicity. , 1987, Journal of immunology.

[149]  S. Sandler,et al.  Inhibitory effects of interleukin 1 on insulin secretion, insulin biosynthesis, and oxidative metabolism of isolated rat pancreatic islets. , 1987, Endocrinology.

[150]  J. Nerup,et al.  Low concentrations of interleukin-1 stimulate and high concentrations inhibit insulin release from isolated rat islets of Langerhans. , 1986, Acta endocrinologica.

[151]  B. Larijani,et al.  Would blockage of cytokines improve the outcome of pancreatic islet transplantation? , 2006, Medical hypotheses.

[152]  G. Fantuzzi,et al.  The Histone Deacetylase Inhibitor ITF2357 Reduces Production of Pro-Inflammatory Cytokines In Vitro and Systemic Inflammation In Vivo , 2005, Molecular medicine.

[153]  K. Xiang,et al.  Genome-wide search for type 2 diabetes/impaired glucose homeostasis susceptibility genes in the Chinese: significant linkage to chromosome 6q21-q23 and chromosome 1q21-q24. , 2004, Diabetes.

[154]  S. Yagihashi,et al.  Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese Type II diabetic patients , 2002, Diabetologia.

[155]  M. Redondo,et al.  Genetics of type 1A diabetes. , 2001, Recent progress in hormone research.

[156]  F. Ece,et al.  Histone deacetylase inhibitor downregulation of bcl-xl gene expression leads to apoptotic cell death in mesothelioma. , 2001, American journal of respiratory cell and molecular biology.

[157]  P. Poulsen,et al.  Heritability of Type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance – a population-based twin study , 1999, Diabetologia.

[158]  G. Shulman,et al.  Overexpression of Glut4 protein in muscle increases basal and insulin-stimulated whole body glucose disposal in conscious mice. , 1995, The Journal of clinical investigation.